{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:42:00Z","timestamp":1780332120340,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bmc.2020.115891","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T12:36:16Z","timestamp":1606394176000},"page":"115891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Design, synthesis, and biological activity of novel semicarbazones as potent Ryanodine receptor1 inhibitors of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Baozhu","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yadong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115891_b0005","doi-asserted-by":"crossref","unstructured":"Reitz C, Mayeux RJBp: Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. 2014;88(4):640\u2013651.","DOI":"10.1016\/j.bcp.2013.12.024"},{"key":"10.1016\/j.bmc.2020.115891_b0010","doi-asserted-by":"crossref","unstructured":"Pistollato F, Ohayon E, Lam A et al. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities. 2016;7(26):38999\u201339016.","DOI":"10.18632\/oncotarget.9175"},{"key":"10.1016\/j.bmc.2020.115891_b0015","doi-asserted-by":"crossref","unstructured":"Pender RJA, Association DtJotA: World Alzheimer Report 2014 Dementia and Risk Reduction. 2014;11(7):P837\u2013P837.","DOI":"10.1016\/j.jalz.2015.06.1858"},{"key":"10.1016\/j.bmc.2020.115891_b0020","doi-asserted-by":"crossref","unstructured":"Xu J, Begley P, Church S et al. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder. 2016;1862(6):1084\u20131092.","DOI":"10.1016\/j.bbadis.2016.03.001"},{"key":"10.1016\/j.bmc.2020.115891_b0025","doi-asserted-by":"crossref","unstructured":"Liu P, Fleete M, Jing Y, et al. Altered arginine metabolism in Alzheimer's disease brains. 2014;35(9):1992\u20132003.","DOI":"10.1016\/j.neurobiolaging.2014.03.013"},{"key":"10.1016\/j.bmc.2020.115891_b0030","doi-asserted-by":"crossref","unstructured":"Inoue K, Tsutsui H, Akatsu H, Hashizume Y, Matsukawa N, Yamamoto T, Toyo'oka TJSr: Metabolic profiling of Alzheimer's disease brains. 2013;3:2364.","DOI":"10.1038\/srep02364"},{"key":"10.1016\/j.bmc.2020.115891_b0035","doi-asserted-by":"crossref","unstructured":"Morrison LD, Smith DD, Kish SJJJoN: Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. 2010;67(3):1328\u20131331.","DOI":"10.1046\/j.1471-4159.1996.67031328.x"},{"key":"10.1016\/j.bmc.2020.115891_b0040","doi-asserted-by":"crossref","unstructured":"Wang X, Sun G, Feng T et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression. 2019;29(10):787\u2013803.","DOI":"10.1038\/s41422-019-0216-x"},{"key":"10.1016\/j.bmc.2020.115891_b0045","doi-asserted-by":"crossref","unstructured":"Ritter JJBjocp: Drugs for Alzheimer's disease. 2012;73(4):501\u2013503.","DOI":"10.1111\/j.1365-2125.2012.04217.x"},{"key":"10.1016\/j.bmc.2020.115891_b0050","doi-asserted-by":"crossref","unstructured":"Birks J, Harvey RJTCdosr: Donepezil for dementia due to Alzheimer's disease. 2003(3):CD001190.","DOI":"10.1002\/14651858.CD001190"},{"key":"10.1016\/j.bmc.2020.115891_b0055","doi-asserted-by":"crossref","unstructured":"Haass C, Selkoe DJNrMcb: Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. 2007;8(2):101\u2013112.","DOI":"10.1038\/nrm2101"},{"key":"10.1016\/j.bmc.2020.115891_b0060","doi-asserted-by":"crossref","unstructured":"Poorkaj P, Kas A, D'Souza I, et al. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. 2001;12(9):700\u2013712.","DOI":"10.1007\/s00335-001-2044-8"},{"key":"10.1016\/j.bmc.2020.115891_b0065","doi-asserted-by":"crossref","unstructured":"Inhibition of protein phosphatases induces transport deficits and axonopathy %J Journal of Neurochemistry. 2010;102(3):878\u2013886.","DOI":"10.1111\/j.1471-4159.2007.04603.x"},{"key":"10.1016\/j.bmc.2020.115891_b0070","doi-asserted-by":"crossref","unstructured":"Zhou L, McInnes J, Wierda K et al. Tau association with synaptic vesicles causes presynaptic dysfunction 2017;8:15295.","DOI":"10.1038\/ncomms15295"},{"key":"10.1016\/j.bmc.2020.115891_b0075","doi-asserted-by":"crossref","unstructured":"Sasaki AJNojotJSoN: Microglia and brain macrophages: An update. 2017;37(5):452\u2013464.","DOI":"10.1111\/neup.12354"},{"key":"10.1016\/j.bmc.2020.115891_b0080","doi-asserted-by":"crossref","unstructured":"Rosenberg P, Nowrangi M, Lyketsos CJMaom: Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits? 2015:25\u201337.","DOI":"10.1016\/j.mam.2015.05.005"},{"key":"10.1016\/j.bmc.2020.115891_b0085","unstructured":"Brian J, Alzheimers BJ. Dementia: Calcium dysregulation in Alzheimer's disease; 2009."},{"key":"10.1016\/j.bmc.2020.115891_b0090","doi-asserted-by":"crossref","unstructured":"Popugaeva E, Pchitskaya E, Bezprozvanny IJB, communications br: Dysregulation of neuronal calcium homeostasis in Alzheimer's disease \u2013 A therapeutic opportunity? 2017;483(4):998\u20131004.","DOI":"10.1016\/j.bbrc.2016.09.053"},{"key":"10.1016\/j.bmc.2020.115891_b0095","doi-asserted-by":"crossref","unstructured":"Bojarski L, Herms J, Kuznicki JJNi: Calcium dysregulation in Alzheimer's disease. 2008;52:621\u2013633.","DOI":"10.1016\/j.neuint.2007.10.002"},{"key":"10.1016\/j.bmc.2020.115891_b0100","doi-asserted-by":"crossref","unstructured":"Brawek B, Garaschuk OJC, research t: Network-wide dysregulation of calcium homeostasis in Alzheimer's disease. 2014;357(2):427\u2013438.","DOI":"10.1007\/s00441-014-1798-8"},{"key":"10.1016\/j.bmc.2020.115891_b0105","doi-asserted-by":"crossref","unstructured":"Fill M, Copello JJPr: Ryanodine receptor calcium release channels. 2002;82(4):893\u2013922.","DOI":"10.1152\/physrev.00013.2002"},{"key":"10.1016\/j.bmc.2020.115891_b0110","doi-asserted-by":"crossref","unstructured":"Bers DJN: Cardiac excitation-contraction coupling 2002;415(6868):198\u2013205.","DOI":"10.1038\/415198a"},{"key":"10.1016\/j.bmc.2020.115891_b0115","doi-asserted-by":"crossref","unstructured":"Van Petegem FJJomb: Ryanodine receptors: allosteric ion channel giants. 2015;427(1):31\u201353.","DOI":"10.1016\/j.jmb.2014.08.004"},{"key":"10.1016\/j.bmc.2020.115891_b0120","doi-asserted-by":"crossref","unstructured":"Yang L, Tautz T, Zhang S, et al. The current status of malignant hyperthermia. 2019;34(2):75\u201385.","DOI":"10.7555\/JBR.33.20180089"},{"key":"10.1016\/j.bmc.2020.115891_b0125","doi-asserted-by":"crossref","unstructured":"Bolognino I, Giangregorio N, Pisani L et al. A prospective repurposing of dantrolene as a multitarget agent for Alzheimer's disease. 2019;24(23).","DOI":"10.3390\/molecules24234298"},{"key":"10.1016\/j.bmc.2020.115891_b0130","doi-asserted-by":"crossref","unstructured":"Chen W, Koop A, Liu Y et al. Reduced threshold for store overload-induced Ca release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease. 2017;474(16):2749\u20132761.","DOI":"10.1042\/BCJ20170282"},{"key":"10.1016\/j.bmc.2020.115891_b0135","doi-asserted-by":"crossref","unstructured":"De Leiris J, Feuvray DJCr: Factors affecting the release of lactate dehydrogenase from isolated rat heart after calcium and magnesium free perfusions 1973;7(3):383\u2013390.","DOI":"10.1093\/cvr\/7.3.383"},{"key":"10.1016\/j.bmc.2020.115891_b0140","doi-asserted-by":"crossref","unstructured":"Peng J, Liang G, Inan S et al. Dantrolene ameliorates cognitive decline and neuropathology in Alzheimer triple transgenic mice. 2012;516(2):274\u2013279.","DOI":"10.1016\/j.neulet.2012.04.008"},{"key":"10.1016\/j.bmc.2020.115891_b0145","doi-asserted-by":"crossref","unstructured":"Chakroborty S, Briggs C, Miller M et al. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. 2012;7(12):e52056.","DOI":"10.1371\/journal.pone.0052056"},{"key":"10.1016\/j.bmc.2020.115891_b0150","doi-asserted-by":"crossref","unstructured":"Brandom BW, Green LM, Alvin MS et al. Complications Associated With the Administration of Dantrolene 1987 to 2006. 2011.","DOI":"10.1213\/ANE.0b013e31820b5f1f"},{"key":"10.1016\/j.bmc.2020.115891_b0155","doi-asserted-by":"crossref","unstructured":"Krause J, Chenard BJAotNYAoS: Opportunities and challenges in the discovery of new central nervous system drugs. 2008;1144:243\u2013250.","DOI":"10.1196\/annals.1418.024"},{"key":"10.1016\/j.bmc.2020.115891_b0160","doi-asserted-by":"crossref","unstructured":"Aoyama H, Doura TJB, letters mc: Selective acetylcholinesterase inhibitors derived from muscle relaxant dantrolene. 2020;30(4):126888.","DOI":"10.1016\/j.bmcl.2019.126888"},{"key":"10.1016\/j.bmc.2020.115891_b0165","doi-asserted-by":"crossref","unstructured":"N'Da C, Petzer A, Petzer JJDr. The inhibition of acetylcholinesterase by dantrolene and ondansetron. 2015, 65(1):46\u201351.","DOI":"10.1055\/s-0034-1372612"},{"issue":"2","key":"10.1016\/j.bmc.2020.115891_b0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2020.115891_b0175","doi-asserted-by":"crossref","unstructured":"Wager T, Chandrasekaran R, Hou X et al. Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes. 2010;1(6):420\u2013434.","DOI":"10.1021\/cn100007x"},{"key":"10.1016\/j.bmc.2020.115891_b0180","doi-asserted-by":"crossref","unstructured":"Bromley-Brits K, Deng Y, Song WJJoveJ: Morris water maze test for learning and memory deficits in Alzheimer's disease model mice 2011(53).","DOI":"10.3791\/2920"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620307215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:10:31Z","timestamp":1760836231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620307215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":36,"alternative-id":["S0968089620307215"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115891","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological activity of novel semicarbazones as potent Ryanodine receptor1 inhibitors of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115891"}}